The genes of the renin-angiotensin system (RAS) play an important role in the regulation of pulmonary vascular tone. Although studies on individual genes polymorphisms have reported association with high-altitude pulmonary oedema (HAPE), studies on multiple genes or epistasis are lacking. We therefore investigated the association of the RAS polymorphisms with HAPE. In a case-control design, we screened 163 HAPE-resistant/controls (HAPE-r) and 160 HAPEpatients (HAPE-p) of Indian origin for eight polymorphisms of four RAS genes, ACE, AGT, AGTR1 and AGTR2. Significant difference in genotype and allele frequencies of the ACE I/D and AGT M235T polymorphisms was observed between HAPE-p and HAPE-r (p < 0.05). In three-locus haplotype analysis of AGT the haplotype GTM was significantly higher in HAPE-p (29%) and haplotype GTT in HAPE-r (27%) after Bonferroni correction (p < 0.006). The differences were insignificant for polymorphisms from AGTR1 and AGTR2. The MDR (multifactor dimensional reduction) approach for gene-gene interaction depicted individual polymorphism M235T as the best disease predicting model (cross validation consistency, CVC = 10/10). We found a significant association of D allele of ACE and M allele of AGT with HAPE. The findings are supported at the haplotypic level as well as through nested genetic interaction between the RAS gene polymorphisms using the MDR approach.
Introduction
High-altitude pulmonary oedema (HAPE) is a noncardiogenic pulmonary oedema that may develop in otherwise healthy individuals on induction to altitudes above 2500 m. 1 The disorder may be caused initially by an increase in pulmonary capillary pressure 2 that leads to stress failure 3 thus leading to high-permeability oedema. In addition, the pulmonary vascular resistance (PVR) in HAPE-patients (HAPE-p) shows a significant hypersensitive response to hypoxia compared with that in HAPEresistant (HAPE-r) subjects. 4 The classical concept of the renin-angiotensin system (RAS) is that it plays an important endocrine role in the maintenance of blood pressure (BP), electrolyte and fluid balance. More importantly in HAPE, RAS plays a crucial role in regulation of pulmonary vascular tone. 5 A direct correlation of its genetic variants with increased plasma renin activity, angiotensin-II (Ang-II) and aldosterone levels was reported, the levels being higher in patients than the controls. 6, 7 On the other hand, angiotensin I-converting enzyme (ACE) level was reported lower in acclimatised subjects. [8] [9] [10] Studies on ACE Alu Insertion/Deletion (I/D) polymorphism reported its association with endurance, 11 high altitude (HA) adaptation, 12 oxygen (O 2 ) saturation 13 and HAPE, 9, 10 but not without conflicts; 10, [14] [15] [16] angiotensinogen (AGT) is reported to marginally associate with HAPE in a Chinese population 17 and angiotensin-II receptor type 1 (AGTR1) was reported to associate with HAPE in Japanese subjects. 10 At variance with the consistency of these results, the genetic markers, e.g. ACE I/D, although having no important effect on susceptibility to AMS or HAPE in Caucasians, 15 were found to be indirectly associated with HAPE in Japanese, 10 a crosstalk with the endothelin-1 gene in Indians 9 and to have a synergistic interaction with the other single nucleotide polymorphisms (SNPs) of this gene in Chinese. 17 The conflicts between these studies may be attributed to various factors, the two most significant among them being environment and ethnicity. Realising the significance of RAS at HA and the pertinent issues, we conducted one of the largest case-control studies on HAPE. The study focused on two objectives: first, to examine whether the common genetic markers of RAS individually differ between HAPE patients and controls at allelic, genotypic or haplotypic levels; second, whether a synergistic interaction between the genes of RAS define the final disease phenotype, using a validated model-free statistical method called multifactor dimensional reduction (MDR). 18
Materials and methods

Patients and healthy volunteers
The Human Ethics Committee of our institute approved the investigation. After obtaining written informed consent from each participant, 10-ml blood samples were drawn. The HAPE-p were recruited through Sonam Norboo Memorial Hospital, Leh (~ 3500 m), India and consisted of 160 male patients broadly of North Indian origin admitted over a period of six years. The diagnosis was based on criteria described in detail earlier, 9, 19 which included assessment of onset of typical symptoms at HA, such as serious hypoxaemia, including cough and dyspnoea at rest, absence of infection, presence of pulmonary rales and cyanosis, disappearance of symptoms and signs within three days of the start of treatment with supplemental oxygen and bed rest. Chest radiographic infiltrates consistent with pulmonary oedema confirmed the disorder. Any previous history of cardiopulmonary diseases was ruled out through a questionnaire and re-examining after recovery.
The age-, gender-and ethnicity-matched HAPE-r (controls) consisted of 163 unrelated healthy male volunteers. They were initially examined at low altitude, Jammu (< 500 m), and later at Leh (~3500 m) and were declared fit. Lake Louise scoring worksheet was applied to rule out any symptoms of acute mountain sickness (AMS) among HAPE-r. The body mass index (BMI) was calculated; BP, arterial oxygen saturation (SaO 2 ) and pulse rate (PR) were measured in the seated position after 10 min of rest. BP was measured using a mercury sphygmomanometer while SaO 2 and PR were measured using a Finger-Pulse Oximeter 503 (Criticare Systems Inc., USA).
Genotyping
Genomic DNA was isolated from peripheral blood leukocytes using the salting-out procedure. 20 The polymorphisms, namely ACE I/D, AGT G-6A, T174M, M235T, AGTR1 A1166C and AGTR2 rs5193, rs5194, rs12845035 were screened by PCR, RFLP and SNaPshot ddNTP Primer Extension PCR (Applied Biosystems, Foster City, USA) methods. The details on the primer sequences and cyclic conditions are listed in table 1. The selection of polymorphic markers in the present study was based on a broader consideration of the criteria of (a) functional relevance, i.e. non-synonymous SNPs (nsSNPs), (b) level of heterozygosity, (c) position in the gene, i.e. promoter and exonic polymorphism and (d) their use in previous studies. ACE I/D is an Alu repeat located in the intron 16 and is one of the most studied markers, associating with a wide spectrum of disease phenotypes including HA disorders. The G-6A, T174M (rs4762) and M235T (rs699) are the most commonly studied SNPs of angiotensinogen (AGT) gene. While G-6A is located in the promoter region, both T174M and M235T are located in exon 2 of AGT. The missense mutations from nucleotide C to T at position 1128 which changes amino acid threonine to methionine (T174M), and from nucleotide T to C at position 1311 which changes amino acid methionine to threonine (M235T) are reportedly associated with various diseases. A consistency with this nomenclature, i.e. T174M and M235T, is maintained in the present study due to its wide use. The A1166C (rs5186) of AGTR1 and G1498T (rs5193), A1504G (rs5194) and C2402G (rs12845035) of AGTR2 are all located in the 3' untranslated region (UTR) region of the gene.
Genotype interactions
The within-gene interactions (haplotype) and betweengenes genotype interactions were investigated.
Statistical analysis
Hardy-Weinberg equilibrium (HWE) was calculated using the chi square (χ 2 ) goodness-of-fit test. Unpaired Student's t-test with two-tailed value was performed to compare the differences in the continuous data between the two groups. Genotype and allele frequency distribution was analysed by χ 2 test with two and one degree of freedom (df). All statistical analyses were performed using SPSS-v.12.0 (SPSS Inc., Chicago, USA). Odds ratio (OR) was calculated for the alleles and genotypes on a 2 × 2 contingency table using Simple Interactive Statistical Analysis (SISA). A two-tailed p-value of < 0.05 was considered statistically significant. The two-locus and three-locus haplotype analysis was performed using the program PHASE v.2.1.1, a model-based Bayesian method 21 under the assumption of coalescence of haplotypes. Haplotype distribution was compared by a likelihood-ratio (LR) test derived from a series of simple 2 × 2 tables based on the frequency of each haplotype separately versus the remaining. The gene-gene interaction was looked at using software MDR v.1.2.2. 18 Multilocus genotypes were pooled into high-risk and low-risk groups, effectively reducing the dimensionality of the genotype predictors. The high-risk genotypes for HAPE were defined as those that have a ratio of cases over controls higher than a certain predicted value.
Results
Baseline characteristics
The baseline characteristics of age-and gender-matched subjects in both groups are presented in table 2. The HAPE-r were frequent visitors to HA (59% visited > 3 times) and none suffered from AMS (AMS score < 4) or other HA-related disorders, even on their earlier visits. A significant difference was observed for BMI, SaO 2 , diastolic blood pressure (DBP) and PR between HAPE-p and HAPE-r (p < 0.01).
Single-locus analysis
The studied polymorphisms were in HWE except for SNPs of AGTR2. The HWE could not be calculated for polymorphisms of AGTR2 in the male subjects as the gene is located on X chromosome. The overall genotype and allelic distribution is presented in table 3. The ACE I/D was significantly associated with HAPE at both the genotypic and the allelic level. On comparing II homozygotes with ID heterozygotes and DD homozygotes a significant difference was obtained (χ 2 = 4.73, p = 0.03 and χ 2 = 6.61, p = 0.01; figure 1a ). At the allelic level the D allele also significantly associated with HAPE (χ 2 = 7.55, p = 0.006, OR = 1.58, 95% confidence interval, CI = 1.14-2.2 at 1 df; figure 1b ). Among the three common polymorphisms of AGT, i.e. G-6A, T174M and M235T, a significant association was found for G-6A and M235T with HAPE (table 3) . The odds of HAPE-r rather than HAPE-p having A-6A was 1.89 (95% CI = 1.14-3.12; χ 2 = 6.16, p < 0.02). The M235T polymorphism was found to be significant in defining the disorder HAPE (p < 0.0001; figure 1, c figure 1c) . Similarly, the difference was also significant for the heterozygous genotype M235T against T235T; the odds being 4.36 (χ 2 = 34.86, 95% CI = 2.64-7.20, p < 0.0001); as a consequence the M allele had greater risk odds, i.e. 3.59 (χ2 = 46.9, 95% CI = 2.47-5.24, p < 0.0001; figure 1d ). Consistent with the database, the M174M genotype of T174M polymorphism was rare (< 2%) in both groups and the polymorphism did not associate with HAPE (table 3) .
Surprisingly, none of the polymorphisms of the receptors type I and type II associated with HAPE (p > 0.05; table 3 ). The C1166C genotype of AGTR1 A1166C polymorphism was rare (< 1.5%) in the two groups.
Haplotyping, within-gene interactions
Pairwise linkage disequilibrium (LD) between the three polymorphisms as Lewontin's coefficient (D') and statistical significance were estimated in both the groups. The D' value between M235T and G-6A polymorphisms was 0.45. The results of two-locus and three-locus haplotypes of AGT gene are presented in table 4. With respect to the two-locus haplotype, a total of 12 haplotypes were observed. The haplotypes 174T_235M and -6G_235M were significantly overrepresented in HAPE-p with risk odds of 3.39 (p < 0.0001, 95% CI = 2.32-4.95) and 2.93 (p < 0.0001, 95% CI = 1.95-4.4), respectively; contrary to this, the haplotypes 174T_235T and -6G_235T were most frequent in HAPE-r with respective odds of 0.36 (p < 0.0001, 95% CI = 0.26-0.51) and 0.44 (p < 0.0001, 95% CI = 0.29-0.66). The role of M235T polymorphism was also prominent in the three-locus haplotype, since the difference for -6G_174T_235M was significant (p < 0.0001) with distribution of 29% in HAPE-p and 13% in HAPE-r; and -6G_174T_235T as 14% in HAPE-p and 27% in HAPE-r (p < 0.0001; table 4). No significant association with the disease was observed for both two-locus and three-locus haplotype of AGTR2 polymorphisms (table 6) . 
Gene-gene interactions
The genotypes interactions among the polymorphisms resulting from the MDR model (CVC = 10/10) depicted individual polymorphism M235T as the best disease predicting model with testing balance accuracy (TBA) of 0.67 (table 5) . The model, however, did not strongly support the interactions among the polymorphism of all the genes. The genotype interactions were drawn between polymorphisms, i.e. ACE I/D and AGT M235T, that individually associated with HAPE ( figure 2 ). The box with dark grey shading indicates high risk, light grey low risk and the blank box no combinations for the given genotype. The role of M235T polymorphism was prominent as all the boxes with homozygote M235M and heterozygote M235T are high risk while that with homozygote T235T is low risk. Of all the genotype interactions, the genotypes II and ID of ACE and T235T of AGT were the most commonly interacting and the ratio indicated it as low risk, highlighting the protective interaction between the I and T alleles of the two genes.
Discussion
In our investigation of the candidate genes of RAS, the ACE I/D polymorphism significantly differed between HAPE-p and HAPE-r with DD homozygote and D allele associating with the disorder HAPE. Under acute hypoxic condition, the D allele is hypothesised to contribute to the hyper-responsive PVR and pulmonary vascular resistance index (PVRI), 10 and its association with higher ACE activity 22 further cumulates its association with HAPE. These findings concurrently uphold the association of I/D polymorphism with higher SaO 2 , 13,23 endurance performance, 11 HA adaptation 12 and HA disorders. 9 This is also consistent with our earlier study wherein the ACE I/D and EDN1 G2288T variants had independent and interactive roles in HAPE susceptibility. 9 AGT is yet another candidate gene having an important role in cardiovascular diseases. Whereas the meta-analysis of T174M from 46 studies and M235T from 137 studies associated 174M and 235T with hypertension, 24, 25 the most prominent finding of the present study was the significant association of 235M with HAPE. The M235M homozygotes were significantly higher among HAPE-p than HAPE-r. Further, at the allelic level the results were more prominent with 235M in HAPE-p. A recent study, though, did not find a much higher percentage of M235M among HAPE-p (58%) compared with HAPE-r (52%); on detailed assessment, however, the odds of having MM and HAPE was 1.33 rather than MT + TT. 17 The role of M235T polymorphism in endurance training had been reported with the variability in left ventricular hypertrophy induced by endurance training, where the athletes homozygous for T allele had the largest hearts 26 ; whereas another study did not find any association of individual polymorphism with left ventricular mass; rather, a synergistic interaction between ACE DD and AGT T235T with left ventricular hypertrophy due to long-term athletic training. 26 The allelic distribution of M235T polymorphism may be attributed to ethnic variability as SNP flip is seen between different populations. 27 The major stress in association studies is on the functional validation of associated SNPs. For example a SNP associating with a disease in one population may not be polymorphic in another population. Besides, as we noticed here, a flip of minor alleles between populations may also add to the complexity. The conflicts in genetic association studies on M235T polymorphism may also be explained by co-factors affecting other components of the RAS. 28 The promoter polymorphism G-6A in our present study was also significantly associated with HAPE. Due to the significance of its location in the promoter region and its stronger LD with M235T, the G-6A polymorphism is hypothesised as having a regulatory role and is well reported for its association with cardiovascular diseases [29] [30] [31] but has not been studied in any of the HA diseases.
The AGTR1 variants did not associate with HA disorders, such as AMS and HAPE, or the athletic performance studied in various ethnic groups. 10, 32, 33 The case with AGTR2 was similar. Nevertheless, it would be of interest to analyse the studied polymorphisms of these two receptors with respect to Ang II levels to ascertain their role in vascular homeostasis.
To further our understanding of the contribution of the interaction of multiple SNPs toward the risk of developing HAPE at HA, we looked for within-gene, i.e. haplotype, and between-genes, i.e. epistasis, interactions. We constructed two-locus and three-locus haplotype for AGT and AGTR2. The haplotype results clearly demonstrated the contribution of the AGT M235T, since the haplotype having M235 allele was significantly over-represented among the HAPE-p both in two-locus and three-locus haplotypes and vice versa for the haplotype having T235 allele. On the other hand, the two-locus and three-locus haplotypes of AGTR2 did not differ between HAPE-p and HAPE-r. With respect to epistasis, we observed interesting interactions between ACE and AGT. The MDR model revealed a likely interaction of ACE D and AGT M235 alleles in the diseased state (such as the genotype DD + MM), and I and T235 alleles (genotype ID + TT and II + TT) of respective gene in controls. The results were in agreement with the findings of individual polymorphism. The within-gene interactions corroborated those of between-gene interactions as the contribution of the respective alleles remained indistinguishable. We nevertheless realised that such interactions were looked for the first time in pursuit of candidate markers of HAPE in the present and previous studies 9 and such investigations are gaining consideration to ascertain the multifactor effect in various complex diseases. 17, 34 
Conclusion
All sets of data, i.e. individual polymorphism, haplotype and MDR, depicted association of D allele of ACE and M allele of M235T with HAPE. It was subsequently validated at the haplotypic level as well as by implying MDR approach for genetic interaction. The results on association of M235T lack any encouraging literature support; nonetheless a significant flip of the allele raises the fundamental query on replication of association results in different ethnic populations. Although both recent experimental and clinical data suggest a central role for RAS in vascular homeostasis, a complete validation of the genetic variants in different human populations is a necessary pre-requisite before moving on to validating their causative role in HAPE or other complex diseases.
